inhaler

(redirected from Metered-dose inhaler)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

inhaler

a device for breathing in therapeutic vapours through the nose or mouth, esp one for relieving nasal congestion or asthma

inhaler

[in′hā·lər]
(medicine)
A device containing a solid medication through which air is drawn into the air passages.
An atomizer containing a liquid medication.
(mining engineering)
An apparatus, of different forms, for permitting the supply of fresh air to a miner.
References in periodicals archive ?
Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers.
Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler Versus Budesonide Dry Powder Inhaler on Pulmonary Function in Black Adolescents and Adults with Moderate to Severe Persistent Asthma [oral presentation].
Controlled breathing is difficult for patients with a terminal illness, and a metered-dose inhaler with a spacer, in addition to allowing the patient to breathe more normally, provides the same drug delivery as using the more invasive and expensive nebulizer," said Dr.
Comparison of Nebuhaler and conventional metered-dose inhaler in elderly patients.
One way to improve delivery is to have the child using a metered-dose inhaler take one puff at a time and hold their breath for 5-10 seconds.
Use of more than two metered-dose inhaler applications per month of inhaled, short-acting [[beta].
On average, 10%-20% of the medication from a metered-dose inhaler makes it into the lower airways.
XOPENEX HFA is a hydrofluoroalkane (HFA) metered-dose inhaler (MDI), which is a portable, hand-held device consisting of a pressurized canister containing medication and a mouthpiece through which the medication is inhaled.
The study evaluated airway function improvement with BROVANA and salmeterol (SEREVENT([R])) metered-dose inhaler compared with placebo over a period of 12 weeks in patients with COPD.
Long-term Safety of Levalbuterol Administered via Metered-Dose Inhaler in Patients with Asthma
This multicenter, double-blind, double-dummy, randomized Phase III study of 717 patients evaluated airway function improvement in patients with COPD who were treated with either arformoterol 50 micrograms, or (mu)g once daily, arformoterol 25 (mu)g twice daily, arformoterol 15 (mu)g twice daily, salmeterol metered-dose inhaler (SEREVENT(R)) 42 (mu)g twice daily, or placebo.